127 related articles for article (PubMed ID: 38678600)
1. Comparison of the efficacy and safety of warfarin anticoagulation and left atrial appendage transcatheter occlusion in the treatment of non-valvular atrial fibrillation and investigation of ET-1, hs-CRP and PDGFs.
Zhang Y; Yao Y; Tao L; Du T; Jia B; Zhou M; Zhang Z
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):225-230. PubMed ID: 38678600
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study.
Block PC; Burstein S; Casale PN; Kramer PH; Teirstein P; Williams DO; Reisman M
JACC Cardiovasc Interv; 2009 Jul; 2(7):594-600. PubMed ID: 19628179
[TBL] [Abstract][Full Text] [Related]
3. PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study.
Bayard YL; Omran H; Neuzil P; Thuesen L; Pichler M; Rowland E; Ramondo A; Ruzyllo W; Budts W; Montalescot G; Brugada P; Serruys PW; Vahanian A; Piéchaud JF; Bartorelli A; Marco J; Probst P; Kuck KH; Ostermayer SH; Büscheck F; Fischer E; Leetz M; Sievert H
EuroIntervention; 2010 Jun; 6(2):220-6. PubMed ID: 20562072
[TBL] [Abstract][Full Text] [Related]
4. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.
Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H
Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
[TBL] [Abstract][Full Text] [Related]
6. Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience.
Price MJ; Reddy VY; Valderrábano M; Halperin JL; Gibson DN; Gordon N; Huber KC; Holmes DR
JACC Cardiovasc Interv; 2015 Dec; 8(15):1925-1932. PubMed ID: 26627989
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.
Holmes DR; Reddy VY; Turi ZG; Doshi SK; Sievert H; Buchbinder M; Mullin CM; Sick P;
Lancet; 2009 Aug; 374(9689):534-42. PubMed ID: 19683639
[TBL] [Abstract][Full Text] [Related]
8. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
[TBL] [Abstract][Full Text] [Related]
9. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.
Holmes DR; Kar S; Price MJ; Whisenant B; Sievert H; Doshi SK; Huber K; Reddy VY
J Am Coll Cardiol; 2014 Jul; 64(1):1-12. PubMed ID: 24998121
[TBL] [Abstract][Full Text] [Related]
10. Left Atrial Appendage Thrombi Formation in Japanese Non-Valvular Atrial Fibrillation Patients During Anticoagulation Therapy - Warfarin vs. Direct Oral Anticoagulants.
Kawabata M; Goya M; Sasaki T; Maeda S; Shirai Y; Nishimura T; Yoshitake T; Shiohira S; Isobe M; Hirao K
Circ J; 2017 Apr; 81(5):645-651. PubMed ID: 28179613
[TBL] [Abstract][Full Text] [Related]
11. Favorable neurological outcome after ischemic cerebrovascular events in patients treated with percutaneous left atrial appendage occlusion compared with warfarin.
Lee OH; Kim YD; Kim JS; Pak HN; Hong GR; Shim CY; Uhm JS; Cho IJ; Joung B; Hong SJ; Ahn CM; Kim BK; Ko YG; Choi D; Hong MK; Yu CW; Lee HJ; Kang WC; Shin ES; Choi RK; Lim DS; Freixa X; Tzikas A; Heo JH; Jang Y; Park JW
Catheter Cardiovasc Interv; 2019 Jul; 94(1):E23-E29. PubMed ID: 30280479
[TBL] [Abstract][Full Text] [Related]
12. Incomplete occlusion of the left atrial appendage with the percutaneous left atrial appendage transcatheter occlusion device is not associated with increased risk of stroke.
Viles-Gonzalez JF; Reddy VY; Petru J; Mraz T; Grossova Z; Kralovec S; Neuzil P
J Interv Card Electrophysiol; 2012 Jan; 33(1):69-75. PubMed ID: 21947786
[TBL] [Abstract][Full Text] [Related]
13. Impact of sex differences on outcomes in patients with non-valvular atrial fibrillation undergoing left atrial appendage closure: A single-center experience.
Zhao M; Post F; Muenzel M; Hou CR; Keil T; Yu J
Int J Med Sci; 2021; 18(9):1990-1998. PubMed ID: 33850469
[TBL] [Abstract][Full Text] [Related]
14. Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation.
Black-Maier E; Piccini JP; Granger CB
J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2968-2976. PubMed ID: 31520437
[TBL] [Abstract][Full Text] [Related]
15. Systematic review on left atrial appendage closure with the LAmbre device in patients with non-valvular atrial fibrillation.
Ali M; Rigopoulos AG; Mammadov M; Torky A; Auer A; Matiakis M; Abate E; Bakogiannis C; Tzikas S; Bigalke B; Sedding D; Noutsias M
BMC Cardiovasc Disord; 2020 Feb; 20(1):78. PubMed ID: 32050904
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous left atrial appendage transcatheter occlusion (PLAATO) for stroke prevention in atrial fibrillation: 2-year outcomes.
Park JW; Leithäuser B; Gerk U; Vrsansky M; Jung F
J Invasive Cardiol; 2009 Sep; 21(9):446-50. PubMed ID: 19726815
[TBL] [Abstract][Full Text] [Related]
17. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.
Viles-Gonzalez JF; Kar S; Douglas P; Dukkipati S; Feldman T; Horton R; Holmes D; Reddy VY
J Am Coll Cardiol; 2012 Mar; 59(10):923-9. PubMed ID: 22381428
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous Left Atrial Appendage Closure in Patients with Non-Valvular Atrial Fibrillation and End-Stage Renal Disease on Hemodialysis: A Case Series.
Basabe E; De La Flor JC; López de la Manzanara V; Nombela-Franco L; Narváez-Mejía C; Cruzado L; Villa D; Zamora R; Tapia M; Sastre MÁ; López Soberón E; Herrero Calvo JA; Suárez A; Martí Sánchez D
Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399519
[TBL] [Abstract][Full Text] [Related]
19. Clinical Results of Left Atrial Appendage Closure with Watchman Device in Patients with Atrial Fibrillation.
Pheerawong P; Songmuang SB; Lertsuwunseri V; Satitthummanid S; Srimahachota S
J Med Assoc Thai; 2015 Oct; 98(10):942-9. PubMed ID: 26638585
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of rivaroxaban on the resolution of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation patients.
Ke HH; He Y; Lv XW; Zhang EH; Wei Z; Li JY
J Thromb Thrombolysis; 2019 Aug; 48(2):270-276. PubMed ID: 31165950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
